U.S. Aerosol Drug Delivery Devices Market Size & Outlook
The aerosol drug delivery devices market in the United States is expected to reach a projected revenue of US$ 18,631.6 million by 2030. A compound annual growth rate of 12.4% is expected of the United States aerosol drug delivery devices market from 2025 to 2030.
- MedTech
- Respiratory Devices
- Aerosol Drug Delivery Devices Market Outlook
- Respiratory Devices
Revenue, 2024 (US$M)
$9,225.6
Forecast, 2030 (US$M)
$18,631.6
CAGR, 2025 - 2030
12.4%
Report Coverage
U.S.
U.S. Aerosol Drug Delivery Devices Market, 2018-2030 (US$M)
Global Market
Related Markets
Ask Prism AI anything about the aerosol drug delivery devices market
Get a cited answer from GVR research in seconds: segment shares, growth drivers, regulation and forecast assumptions.
Every answer starts with GVR research, and every figure is cited.Explore Prism AI
U.S. aerosol drug delivery devices market highlights
- The U.S. aerosol drug delivery devices market generated a revenue of USD 9,225.6 million in 2024 and is expected to reach USD 18,631.6 million by 2030.
- The U.S. market is expected to grow at a CAGR of 12.4% from 2025 to 2030.
- In terms of segment, inhaler was the largest revenue generating type in 2024.
- Inhaler is the most lucrative type segment registering the fastest growth during the forecast period.
Aerosol drug delivery devices market data book summary
| Market revenue in 2024 | USD 9,225.6 million |
| Market revenue in 2030 | USD 18,631.6 million |
| Growth rate | 12.4% (CAGR from 2025 to 2030) |
| Largest segment | Inhaler |
| Fastest growing segment | Inhaler |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Inhaler, Nebulizer |
Other key industry trends
- In terms of revenue, U.S. accounted for 31.0% of the global aerosol drug delivery devices market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. aerosol drug delivery devices market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 4,485.1 million by 2030.
No credit card required*
Publish Date: Feb 03, 2025
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Aerosol Drug Delivery Devices Market Scope
Aerosol Drug Delivery Devices Market segmentation & scope
Aerosol Drug Delivery Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Novartis AG ADR | View profile | 76,057 | Lichtstrasse 35, Basel, Switzerland, 4056 | www.novartis.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37,851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | www.tevapharm.com |
| OMRON Corp | View profile | 28,034 | Shiokoji Horikawa, Shimogyo-ku, Kyoto, Japan, 600-8530 | www.omron.co.jp |
| Sanofi SA | View profile | 87,994 | 46, avenue de la Grande Armée, Paris, France, 75017 | www.sanofi.com |
| AptarGroup Inc | View profile | 13,800 | 265 Exchange Drive, Suite 301, Crystal Lake, IL, United States, 60014 | www.aptar.com |
| Beurer | View profile | 501-1000 | Ulm, Baden-Wurttemberg, Germany, Europe | www.beurer.com/web/us/ |
| AstraZeneca PLC | View profile | 89,900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | www.astrazeneca.com |
| Drive Medical | View profile | 1001-5000 | Port Washington, New York, United States, North America | www.drivemedical.com/ |
| Sensirion | View profile | 1001-5000 | Stafa, Zurich, Switzerland, Europe | www.sensirion.com |
| Aerogen | View profile | 251-500 | Galway, Galway, Ireland, Europe | www.aerogen.com |
U.S. Aerosol Drug Delivery Devices Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Aerosol Drug Delivery Devices Market Outlook will help companies and investors design strategic landscapes.
Inhaler was the largest segment with a revenue share of 89.61% in 2024.
Horizon Databook has segmented the U.S. aerosol drug delivery devices market based on inhaler, nebulizer covering the revenue growth of each sub-segment from 2018 to 2030.
- U.S. Aerosol Drug Delivery Devices Market Type Outlook (Revenue, USD Million , 2018-2030)
- Inhaler
- Nebulizer
- U.S. Aerosol Drug Delivery Devices Market Application Outlook (Revenue, USD Million , 2018-2030)
- COPD
- Asthma
- Cystic Fibrosis
- Other
- U.S. Aerosol Drug Delivery Devices Market Distribution Channel Outlook (Revenue, USD Million , 2018-2030)
- Institutional Pharmacies (Hospital Owned Pharmacies)
- Retail Pharmacies
- Online Pharmacies
Reasons to subscribe to Aerosol Drug Delivery Devices Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Aerosol Drug Delivery Devices Market Outlook databook
- Our clientele includes a mix of Aerosol Drug Delivery Devices Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. Aerosol Drug Delivery Devices Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.S. Aerosol Drug Delivery Devices Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
U.S. Aerosol Drug Delivery Devices Market, 2018-2030 (US$M)
US Type - Aerosol Drug Delivery Devices Market Statistics, 2024 - 2030 (US$M)
